Delivery Order SPE2DB22D2007-SPE2DB24FJ0UF
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $10,286.56, is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VRAYLAR 3 MG CAPSULE 30S, a prescription medication, with a ceiling value of $20,990.56 and a period of performance through May 16, 2025. The contract is not set-aside and was awarded on May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a prescription medication. The contract has a ceiling value of $1,332.14 and a completion date of June 23, 2025. The contract is not set aside and is awarded as an open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $7,197.36 and a period of performance through July 1, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a $3,492.21 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 8, 2025. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, with a ceiling value of $22,172.49 and a completion date of July 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a $12,895.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a prescription medication. It has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VRAYLAR 3 MG CAPSULE 30S, a medication, with a ceiling value of $3,504.12 and a period of performance through June 23, 2025. The contract is a firm-fixed-price delivery order and is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,801.34, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of March 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,597.25, is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0UFDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $8,075.94 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 3/20/24 |